“…IL‐18 acts through NF‐κB for the modulation of many of the inflammatory responses (Akira, ; Kojima et al, ). IL‐18 induces T‐lymphocyte activity via NF‐κB pathway (Weinstock, Blum, Metwali, Elliott, & Arsenescu, ), it can induce IL‐1, TNF‐α, and IL‐6 expression by NF‐κB dependent pathway (Kojima et al, ; Liu, Zhang, Joo, & Sun, ); therefore, many aspects of IL‐18 inflammation are mediated through NF‐κB signaling pathways (Donate‐Correa, Martín‐Núñez, Muros‐de‐Fuentes, Mora‐Fernández, & Navarro‐González, ; Kojima et al, ; Matsumoto et al, ).…”